[1] Evaluation and treatment of recurrent pregnancy loss:a committee opinion[Z].2012:98,1103-1111.
[2] 张建平,林其德,李大金,等.复发性流产的诊断与治疗[J].现代妇产科进展,2006(07):481-492.
[3] TALEBI A R,FESAHAT F,MANGOLI E,et al.Relationship between sperm protamine deficiency and apoptosis in couples with unexplained repeated spontaneous abortions[J].Int J Reprod Biomed (Yazd),2016,14(3):199-204.
[4] 中华医学会妇产科学分会产科学组.复发性流产诊治的专家共识[J].中华妇产科杂志,2016(1):3-9.
[5] 朱劲松,高英敏,王海琳.复发性流产患者蜕膜中T淋巴细胞及其亚群变化的研究[J].中国妇幼保健,2006(10):1405-1406.
[6] 郭玉琪,李晓倩,张俊清,等.复发性流产患者免疫治疗前后T淋巴细胞表达率与治疗效果的临床观察[J].中国计划生育学杂志,2014,22(1):41-43.
[7] CLARK D A,CHAOUAT G,WONG K,et al.Tolerance mechanisms in pregnancy:a reappraisal of the role of class I paternal MHC antigens[J].Am J Reprod Immunol,2010,63(2):93-103.
[8] 林其德,邱丽华.免疫型复发性流产的发病机制及诊断和治疗[J].上海交通大学学报:医学版,2009,29(11):1275-1278.
[9] LIU Z,XU H,KANG X,et al.Allogenic Lymphocyte Immunotherapy for Unexplained Recurrent Spontaneous Abortion:A Meta-Analysis[J].Am J Reprod Immunol,2016,76(6):443-453.
[10] 彭婀娜,姚若进.不明原因复发性流产主动免疫治疗前后封闭抗体的变化及其意义[J].实用妇产科杂志.2010,26(10):773-775.
[11] MOTAK-POCHRZST H,MALINOWSKI A.The efficacy of paternal lymphocytes immunizations in patients with recurrent miscarriages and the presence of autoantibodies[J].J Reprod Immunol,2016,115:68.
[12] PANDEY M K,AGRAWAL S.Induction of MLR-Bf and protection of fetal loss:a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion[J].Int Immunopharmacol,2004,4(2):289-298.
[13] 张劲丰,杨延斌,苏荣,等.封闭抗体在不同孕育状态妇女中的分布规律[J].中国妇幼保健,2013,28(2):298-300.
[14] RUSSELL P,SACKS G,TREMELLEN K,et al.The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure.Ⅲ:Further observations and reference ranges[J].Pathology,2013,45(4):393-401.
[15] HEMBERGER M.Immune balance at the foeto-maternal interface as the fulcrum of reproductive success[Z].2013:97,36-42.
[16] LAIRD S M,TUCKERMAN E M,Li T.Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage[J].Reprod Biomed Online,2006,13(1):13-23.
[17] LI X F,CHARNOCK-JONES D S,ZHANG E,et al.Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells[J].J Clin Endocrinol Metab.2001,86(4):1823-1834.
[18] HANNA J,GOLDMAN-WOHL D,HAMANI Y,et al.Decidual NK cells regulate key developmental processes at the human fetal-maternal interface[J].Nat Med,2006,12(9):1065-1074.
[19] PICCINNI M P.T cell tolerance towards the fetal allograft[J].J Reprod Immunol,2010,85(1):71-75.
[20] PETROFF M G,PERCHELLET A.B7 family molecules as regulators of the maternal immune system in pregnancy[J].Am J Reprod Immunol,2010,63(6):506-519.
[21] CHRISTIANSEN O B,NIELSEN H S,PEDERSEN B.Active or passive immunization in unexplained recurrent miscarriage[J].J Reprod Immunol,2004,62(1-2):41-52.
[22] GNAINSKY Y,GRANOT I,ALDO P B,et al.Local injury of the endometrium induces an inflammatory response that promotes successful implantation[J].Fertil Steril,2010,94(6):2030-2036.
[23] SOLIMAN B S,HARIRA M.Local endometrial scratching under ultrasound-guidance after failed intrauterine insemination and cycle outcome:A randomized controlled trial[J].Middle East Fertil Steril J,2016, 22(1):60-66.
[24] SACKS G.Enough! Stop the arguments and get on with the science of natural killer cell testing[J].Hum Reprod,2015,30(7):1526-1531.
[25] PATEL B G,LESSEY B A.Clinical assessment and management of the endometrium in recurrent early pregnancy loss[J].Semin Reprod Med,2011,29(6):491-506. |